Alzheimer's Disease
Neurology
Prevalence
700.0 / 100K
Incidence
120.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| vy7523 | Voyager Therapeutics, Inc. (VYGR) |
Frequently asked questions
How many drugs are in development for Alzheimer's Disease?
BioSniper tracks 1 drug in development for Alzheimer's Disease across 1 company.
How many clinical trials target Alzheimer's Disease?
There are 1 clinical trial targeting Alzheimer's Disease tracked by BioSniper.
What is the prevalence of Alzheimer's Disease?
The estimated prevalence of Alzheimer's Disease is approximately 700.0 per 100,000 population.
Deep-dive into Alzheimer's Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis